All vendors
I

Imagine First peptides: prices, COAs and vendor facts

21 tracked listings · 17 productsVisit site

Imagine First is a research-peptide vendor that lists 21 injectable peptides, including BPC-157, Ipamorelin and NAD+. Across 21 products with a market median, its prices sit 6% above the median for the same peptide and vial size; it is the cheapest vendor we track on BPC-157 and Kisspeptin-10, and pricier on GHK-Cu and Retatrutide. We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index.

What the record shows

COA coverage: None found

We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index.

Current certificates
0

from 0 indexed documents

Tested within a year
0

current certificates, by the date printed on them

Labs named
0

named on 0 certificates

Freshest test date
None printed

across current certificates

Price position

Popular
7% above market
on 14 popular peptides
Catalog
6% above market
$$$ price level · 21 listings
Peptides
17
14 popular carried
COA coverage, in stock
None found
Based on the certificates our crawler found; vendors may publish more than we index.
Cheapest on
  • BPC-157▼ 11%
  • Kisspeptin-10▼ 11%
  • Ipamorelin▼ 11%
Pricier on
  • GHK-Cu▲ 46%
  • Retatrutide▲ 23%
  • AOD-9604▲ 18%

Price check

Listed prices at Imagine First against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.

Below the market median on 6 of 17 comparable listings, above it on 10. Typical listing: 6% above market. Showing the 6 largest differences.

How does Imagine First compare to other peptide vendors?

Imagine First sits 6% above market the tracked market median on matched peptide/size rows. The catalog in this index is smaller than Nationwide Peptides's. On COA coverage, Imagine First rates none found and Nationwide Peptides rates partial. Based on the certificates our crawler found; vendors may publish more than we index.

The honest comparison unit is price per mg on matched peptide/size rows. COA coverage is presence of a current indexed document, not purity-as-quality. See the Evidence Atlas and how to read a COA.

Evidence boundary: Listed prices, stock signals, and indexed COA documents are observations. They do not establish legitimacy, authenticity, safety, sterility, chain of custody, product quality, fulfillment, or suitability. No vendor is endorsed.

14 of 22 carried

Full catalog (17)

Questions about Imagine First

Is Imagine First legit?

Pricing data cannot settle that question, and we do not test products or verify fulfillment. Here is the evidence we do hold for Imagine First. We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index. Read each certificate yourself, check that its lot and compound match what you are buying, and treat anything we have not recorded as unknown rather than as an answer.

Does Imagine First publish COAs?

We found no certificates for the in-stock products we track. Based on the certificates our crawler found; vendors may publish more than we index. We have not recorded a testing or COA page on their site. A certificate on file records what a document says; it cannot prove chain of custody or what is in the vial you receive.

How do Imagine First prices compare to other vendors?

Across 21 graded products, Imagine First's median price per mg sits 6.2% above the median for the same peptide at the same vial size. We track 17 products from them in total. Price per mg is the comparison unit: a cheaper vial holding less is not a cheaper product.

Product documentation

Imagine First COA coverage

Across the tracked peptide products we hold for Imagine First, COA coverage rates none found. The public index contains 0 documents. That rating covers the full tracked catalogue for Imagine First, including products that are currently out of stock, so it can differ from the in-stock rating above. Based on the certificates our crawler found; vendors may publish more than we index.

Product coverage
None found

across the full tracked catalogue

Tested in past year
0

current certificates, by the printed test date.

Older records
0

Printed date is over 18 months old.

Most named lab
Not reported

No current record names a lab.

No current certificates are on file for the tracked market listings on this page.

A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.

These are counts of documents in our index, and a coverage rating of what our crawler found. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.

See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.

Cite this profile

The Peptide App. Imagine First peptide prices, COA coverage and vendor facts. Updated September 29, 2026. https://www.thepeptide.app/pricing/vendor/imagine-first

The Peptide App. (2026). Imagine First peptide prices, COA coverage and vendor facts. Retrieved from https://www.thepeptide.app/pricing/vendor/imagine-first

Prices and certificate counts on this page were last refreshed September 29, 2026.

Market tape